Passage Bio regains Nasdaq minimum bid price compliance; listing matter closed

Passage BIO, Inc.

Received Nasdaq notice on July 28, 2025 confirming compliance with Listing Rule 5450(a)(1).
Closing bid price was at least $1.00 per share for 10 consecutive business days as of July 28.
Had been non-compliant since August 1, 2024 due to bid price below $1.00 for 30 consecutive days.
Listing matter now closed; company continues on Nasdaq Capital Market.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.